The FDA has warned people several times about the dangers of this
Safety netting at Slinic for complex cases involves: Rigorous Baseline Testing: Mandatory blood panels before the first dose is dispatched
In the Falutz 2010 trials, once-daily dosing at 2 mg produced mean IGF-1 increases that normalized toward baseline over the 26-week trial, suggesting some receptor adaptation without complete desensitization
Approximately 21% of the 159 adult patients in the 400 mg/day group who received topiramate as monotherapy in the controlled clinical trial discontinued therapy due to adverse events
References Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a bloodborne non-A, non-B hepatitis genome
Regular check-ins, precise dose adjustments, and supportive lifestyle recommendations create a safe and encouraging environment